(DHQ)2PYR is widely used as a chiral ligand in asymmetric synthesis, particularly in catalytic asymmetric hydrogenation reactions. It plays a crucial role in the production of enantiomerically pure compounds, which are essential in the pharmaceutical industry for the synthesis of active pharmaceutical ingredients (APIs). The ligand is also employed in the development of chiral catalysts for organic transformations, such as carbon-carbon bond formation and reduction reactions, enhancing the efficiency and selectivity of these processes. Additionally, (DHQ)2PYR is utilized in academic research to study and develop new asymmetric catalytic systems, contributing to advancements in synthetic organic chemistry.